Literature DB >> 27072206

Seesaw of matrix metalloproteinases (MMPs).

Charu Kapoor1, Sharad Vaidya, Vijay Wadhwan, Geetpriya Kaur, Aparna Pathak.   

Abstract

The family of human matrix metalloproteinases (MMPs) comprises several tightly regulated classes of proteases. These enzymes and their specific inhibitors play important roles in tumor progression and the metastatic process by facilitating extracellular matrix (ECM) degradation. As scientific understanding of the MMPs has advanced, therapeutic strategies focusing on blocking these enzymes by MMP inhibitors (MMPIs) have rapidly developed. This paper reviews MMPs in detail. Their perspectives in therapeutic intervention in cancer are also mentioned.

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27072206     DOI： 10.4103/0973-1482.157337

Source DB:  PubMed          Journal:  J Cancer Res Ther        ISSN： 1998-4138            Impact factor:   1.805


  54 in total

Review 1.  Matrix Metalloproteinase Inhibitors in Cancer Therapy: Turning Past Failures Into Future Successes.

Authors:  Arthur Winer; Sylvia Adams; Paolo Mignatti
Journal:  Mol Cancer Ther       Date:  2018-05-07       Impact factor: 6.261

Review 2.  The Roles of Matrix Metalloproteinases and Their Inhibitors in Human Diseases.

Authors:  Griselda A Cabral-Pacheco; Idalia Garza-Veloz; Claudia Castruita-De la Rosa; Jesús M Ramirez-Acuña; Braulio A Perez-Romero; Jesús F Guerrero-Rodriguez; Nadia Martinez-Avila; Margarita L Martinez-Fierro
Journal:  Int J Mol Sci       Date:  2020-12-20       Impact factor: 5.923

3.  Dietary fat stimulates pancreatic cancer growth and promotes fibrosis of the tumor microenvironment through the cholecystokinin receptor.

Authors:  Sandeep Nadella; Julian Burks; Abdulhameed Al-Sabban; Gloria Inyang; Juan Wang; Robin D Tucker; Marie E Zamanis; William Bukowski; Narayan Shivapurkar; Jill P Smith
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-06-21       Impact factor: 4.052

Review 4.  Matrix metalloproteinase contribution in management of cancer proliferation, metastasis and drug targeting.

Authors:  Nabil M Abdel-Hamid; Shimaa A Abass
Journal:  Mol Biol Rep       Date:  2021-08-11       Impact factor: 2.316

5.  Evaluation of the multiple tissue factors in bone of primary osteoplasty and rhinoplasty in patients affected by cleft lip palate.

Authors:  Dace Buile; Māra Pilmane; Ilze Akota
Journal:  Histol Histopathol       Date:  2022-03-18       Impact factor: 2.130

6.  ASIC1α up-regulates MMP-2/9 expression to enhance mobility and proliferation of liver cancer cells via the PI3K/AKT/mTOR pathway.

Authors:  Yinci Zhang; Jiaojiao Liang; Niandie Cao; Jiafeng Gao; Yinghai Xie; Shuping Zhou; Xiaolong Tang
Journal:  BMC Cancer       Date:  2022-07-16       Impact factor: 4.638

7.  Effect of tissue inhibitor of metalloproteinases-3 genetics polymorphism on clinicopathological characteristics of uterine cervical cancer patients in Taiwan.

Authors:  Jui-Fu Chung; Chia-Lin Chen; Yasser Nassef; Bei-Hao Shiu; Chun-Hao Wang; Fu-Hsuan Kuo; Yi-Hsuan Hsiao; Shun-Fa Yang; Po-Hui Wang
Journal:  Int J Med Sci       Date:  2022-05-29       Impact factor: 3.642

Review 8.  Regulation and Function of Matrix Metalloproteinase-13 in Cancer Progression and Metastasis.

Authors:  Shun Li; David Mark Pritchard; Lu-Gang Yu
Journal:  Cancers (Basel)       Date:  2022-07-03       Impact factor: 6.575

9.  CCN3 suppresses TGF-β1-induced extracellular matrix accumulation in human mesangial cells in vitro.

Authors:  Hai-Fei Liu; Hong Liu; Lin-Li Lv; Kun-Ling Ma; Yi Wen; Long Chen; Bi-Cheng Liu
Journal:  Acta Pharmacol Sin       Date:  2017-08-31       Impact factor: 6.150

Review 10.  The Dynamic Interaction between Extracellular Matrix Remodeling and Breast Tumor Progression.

Authors:  Jorge Martinez; Patricio C Smith
Journal:  Cells       Date:  2021-04-29       Impact factor: 6.600
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.